Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer(407 views) Biondi B, Palmieri EA, Pagano L, Klain M, Scherillo G, Salvatore M, Fenzi G, Lombardi G, Fazio S
Dept. of Clin./Molec. Endocrinol./O., Univ. of Naples Federico II S. of M., 80131 Naples, Italy
Dept. of Clin. Med./Cardiovasc. Sci., Univ. of Naples Federico II S. of M., 80131 Naples, Italy
Dept. of Biomorphological/Funct. S., Univ. of Naples Federico II S. of M., 80131 Naples, Italy
Dept. of Clin. /Molec. Endocrinol. /O., Univ. of Naples Federico II S. of M., 80131 Naples, Italy
References: Mazzaferri, E.L., Jhiang, S.M., Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer (1994) Am J Med, 97, pp. 418-42
Singer, P.A., Cooper, D.S., Daniels, G.H., Ladenson, P.W., Greenspan, F.S., Levy, E.G., Braverman, L.E., Dorfman, S.G., Treatment guidelines for patients with thyroid nodules and well differentiated thyroid cancer (1996) Arch Inter Med, 156, pp. 2168-2172
Solomon, L., Wartofsky, L., Burman, K.D., Current trends in the management of well differentiated thyroid carcinoma (1996) J Clin Endocrinol Metab, 81, pp. 333-339
Schlumberger, M.J., Papillary and follicular thyroid carcinoma (1998) N Engl J Med, 338, pp. 297-306
Pacini, F., Lari, R., Mazzeo, S., Grasso, L., Taddei, D., Pinchera, A., Diagnostic value of a single serum thyroglobuiin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer (1985) Clin Endocrinol (Oxf), 23, pp. 405-411
Maxon H.R. III, Smith, H.S., Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer (1980) Endocrinol Metab Clin North Am, 19, pp. 685-718
Wieshammer, S., Keck, F.S., Waitzinger, J., Kohler, J., Adam, W., Stauch, M., Pfeiffer, E.F., Left ventricular function at rest and during exercise in acute hypothyroidism (1988) Br Heart J, 60, pp. 204-211
Fazio, S., Biondi, B., Lupoli, G., Cittadini, A., Santomauro, M., Tommaselli, A.P., Lombardi, G., Sacca, L., Evaluation by noninvasive method of the effects of acute loss of thyroid hormone on the heart (1992) Angiology, 43, pp. 287-293
Grossmann, G., Wieshammer, S., Keck, F.S., Goller, V., Giesler, M., Hombach, V., Doppler echocardiographic evaluation of left ventricular diastolic function in acute hypothyroidism (1994) Clin Endocrinol (Oxf), 40, pp. 227-233
Mohr-Kahaly, S., Kahaly, G., Konig, P., Cardiac function in short-term hypothyroidism (1994) Heart and Thyroid, pp. 147-149. , Braverman LE, Eber O, Langsteger W, eds. Wien, Austria: Blackwell MZV
Weissel, M., Punzengruber, C., Influence of L-thyroxine replacement therapy on cardiac function of athyreotic thyroid cancer patients. An echophonocardiographic study (1994) Heart and Thyroid, pp. 147-149. , Braverman LE, Eber O, Langsteger W, eds. Wien, Austria: Blackwell MZV
Bengel, F.M., Nekolla, S.G., Ibrahim, T., Weniger, C., Ziegler, I., Schwaiger, M., Effect of thyroid hormones on cardiac function, geometry and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging (2000) J Clin Endocrinol Metab, 85, pp. 1822-1827
Meier, C.A., Braverman, L.E., Ebner, S.A., Veronikis, I., Daniels, G.H., Ross, D.S., Deraska, D.J., Weintraub, B.D., Diagnostic use of recombinant human throtropin in patients with thyroid carcinoma (phase I/II study) (1994) J Clin Endocrinol Metab, 78, pp. 188-196
Ladenson, P.W., Braverman, L.E., Mazzaferri, E.L., Brucker-Davis, F., Cooper, D.S., Garber, J.R., Wondisford, F.E., Weintraub, B.D., Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid administration for radioactive iodine scanning in patients with thyroid carcinoma (1997) N Engl J Med, 337, pp. 888-896
Haugen, B.R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P.W., Sherman, S.I., Cooper, D.S., Ridgway, E.C., A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer (1999) J Clin Endocrinol Metab, 84, pp. 3877-3885
Down, K.H., Ferrell, B.R., Anello, C., Quality of life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy (1997) Thyroid, 7, pp. 613-619
Drvota, V., Janson, A., Norman, C., Sylven, C., Haggblad, J., Bronnegard, M., Marcus, C., Evidence for the presence of functional thyrotropin receptor in cardiac muscle (1995) Biochem Biophys Res Commun, 211, pp. 426-431
Koshiyama, H., Sellitti, D.F., Akamizu, T., Doi, S.Q., Takeuchi, Y., Inoue, D., Sakaguchi, H., Nakao, K., Cardiomiopathy associated with Grave's disease (1996) Clin Endocrinol (Oxf), 45, pp. 111-116
Sellitti, D.F., Hill, R., Doi, S.Q., Akamizu, T., Czaja, J., Tao, S., Koshiyama, H., Differential expression of thyrotropin receptor mRNA in the porcine heart (1996) Thyroid, 7, pp. 641-646
Busuttil, B.E., Frauman, A.G., Extrathyroidal manifestations of Graves' disease: The thyrotropin receptor is expressed in extraocular, but not cardiac muscle tissues (2001) J Clin Endocrinol Metab, 86, pp. 2315-2319
Biondi, B., Fazio, S., Carella, C., Amato, G., Cittadini, A., Lupoli, G., Sacca, L., Lombardi, G., Cardiac effects of long-term thyrotropin-suppressive therapy with levothyroxine (1993) J Clin Endocrinol Metab, 77, pp. 334-338
Cittadini, A., Fazio, S., D'Ascia, C., Basso, A., Bazzicalupo, L., Picardi, G., Sacca, L., Subclinical cardiotoxicity by doxorubicin: A pulse Doppler echocardiographic study (1991) Eur Heart J, 12, pp. 1000-1005
Sellitti, D.F., Doi, S.Q., Akamizu, T., Koshiyama, H., Comment on "Thyrotropin receptor expression in cardiac muscle tissue." (2002) J Clin Endocrinol Metab, 87, p. 946
Nagayama, Y., Tanaka, K., Hara, T., Namba, H., Yamashita, S., Taniyama, K., Niwa, M., Involvement of G protein-coupled receptor kinase 5 in homologous desensitization of the thyrotropin receptor (1996) J Biol Chem, 271, pp. 10143-10148
Sellitti, D.F., Dennison, D., Akamazu, T., Doi, S.Q., Kohn, L.D., Kashiyama, B., Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells (2000) Thyroid, 10, pp. 219-225
Murray, K.J., Cyclic AMP and mechanisms of vasodilation (1990) Pharmacol Ther, 47, pp. 329-345
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer
Eleven patients who had undergone total thyroidectomy for differentiated thyroid cancer and who were on chronic TSH-suppressive therapy with levothyroxine (L-T4), underwent 24-h Holter electrocardiogram and Doppler-echocardiography before and after acute recombinant human TSH (rhTSH) administration for disease staging. The treatment, which was generally well tolerated, did not affect circulating thyroid hormones levels, nor did it have measurable effects on heart rate, rhythm, left ventricular morphology, or systo-diastolic function. Notably, arterial blood pressure tended to be slightly reduced after rhTSH administration, although in no instance did the patients become frankly symptomatic. Our data demonstrate that rhTSH does not alter cardiovascular function acutely. Consequently, it can safely be used in the routine staging of patients affected by differentiated thyroid cancer.
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer
No results.
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer